Evidence map›Paper›PMID 35481029›Full record

ReviewRSC advances2021

Potentialities of bioinspired metal and metal oxide nanoparticles in biomedical sciences.

Kshitij Rb Singh, Vanya Nayak, Jay Singh, Ajaya Kumar Singh, Ravindra Pratap Singh

Open access · goldAbstract readReview
In one paragraph

Review in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Biogenic metallic nanoparticles: from green synthesis to clinical translation.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. NiFeRSC advances · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kshitij Rb SinghDepartment of Chemistry, Govt. V.Y.T. PG Autonomous College Durg Chhattisgarh (491001) India.ORCID https://orcid.org/0000-0002-7846-0010
Vanya NayakDepartment of Biotechnology, Faculty of Science, Indira Gandhi National Tribal University Amarkantak Madhya Pradesh (484886) India rpsnpl69@gmail.com ravindra.singh@igntu.ac.in +91-91-0934-6565.ORCID https://orcid.org/0000-0002-2180-8012
Jay SinghDepartment of Chemistry, Institute of Science, Banaras Hindu University Varanasi Uttar Pradesh (221005) India.ORCID https://orcid.org/0000-0002-3793-0450
Ajaya Kumar SinghDepartment of Chemistry, Govt. V.Y.T. PG Autonomous College Durg Chhattisgarh (491001) India.ORCID https://orcid.org/0000-0001-8180-7292
Ravindra Pratap SinghDepartment of Biotechnology, Faculty of Science, Indira Gandhi National Tribal University Amarkantak Madhya Pradesh (484886) India rpsnpl69@gmail.com ravindra.singh@igntu.ac.in +91-91-0934-6565.ORCID https://orcid.org/0000-0002-6790-4261
Indira Gandhi National Tribal University · INShanghai Institute for Science of Science · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, various reports have shown that metallic gold bhasma at the nanoscale form was used as medicine as early as 2500 B.C. in India, China, and Egypt. Owing to their unique physicochemical, biological, and electronic properties, they have broad utilities in energy, environment, agriculture and more recently, the biomedical field. The biomedical domain has been used in drug delivery, imaging, diagnostics, therapeutics, and biosensing applications. In this review, we will discuss and highlight the increasing control over metal and metal oxide nanoparticle structures as smart nanomaterials utilized in the biomedical domain to advance the role of biosynthesized nanoparticles for improving human health through wide applications in the targeted drug delivery, controlled release drug delivery, wound dressing, tissue scaffolding, and medical implants. In addition, we have discussed concerns related to the role of these types of nanoparticles as an anti-viral agent by majorly highlighting the ways to combat the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, along with their prospects.

Identifiers

PMID35481029
PMCPMC9036962
OpenAlexW3186419044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.